Skip to main content
Top
Published in: Cancer Causes & Control 9/2013

01-09-2013 | Original paper

Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study

Authors: Ping-Ping Bao, Ying Zheng, Sarah Nechuta, Kai Gu, Hui Cai, Peng Peng, Xiao-Ou Shu, Wei Lu

Published in: Cancer Causes & Control | Issue 9/2013

Login to get access

Abstract

Metabolic syndrome (MetS) is an established risk factor for cardiovascular diseases and mortality. Limited data are available on the prevalence of MetS and its association with exercise among breast cancer survivors. The present study included 1,696 breast cancer survivors from the Shanghai Breast Cancer Survival Study, a population-based prospective cohort study conducted between April 2002 and October 2011 in Shanghai, China. All women had a physical examination taken at study clinic approximately 60 months post-diagnosis. Exercise was assessed at approximately 6, 18, 36, and 60 months post-diagnosis. Information on medical history, tumor characteristics, cancer treatment, anthropometrics, and lifestyle was collected at study enrollment. Associations between exercise and MetS at 60 months post-diagnosis were evaluated with multivariable logistic regression models. The mean age of the study population was 56.68 at 60-month survey, and the mean follow-up since cancer diagnosis was 63.66 months. The prevalence of MetS using National Cholesterol Education Program Adult Treatment Panel III criteria at approximately 60 months after diagnosis was 33.14 %. Among overweight and obesity breast cancer survivors (body mass index (BMI) ≥ 25 kg/m2 at baseline), the prevalence was 55.18 %. The most common type of exercise in this population was walking (45.40 %) at baseline. Exercise participation between 6 and 60 months post-diagnosis was inversely associated with the prevalence of MetS with the adjusted odds ratio (OR) for exercise participation of ≥3.5 h/week (30 min/day) being 0.69 (95 % confidence interval (CI) 0.48–0.98). In addition consistent exercise participation reduced the prevalence of MetS (adjusted OR 0.70 (95 % CI 0.50–1.00). Associations of exercise with MetS were not modified by baseline waist circumference, BMI, comorbidity, baseline menopausal status, TNM stage, cancer treatment, or ER/PR status (p interactions >0.05). Regular and persistent exercise after cancer diagnosis, even at low-to-moderate intensity level, decreases the prevalence of MetS among long-term breast cancer survivors.
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D (2010) GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon Ferlay J, Shin HR, Bray F, Forman D (2010) GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon
2.
go back to reference Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241PubMedCrossRef Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241PubMedCrossRef
3.
go back to reference Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80PubMedCrossRef Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80PubMedCrossRef
4.
go back to reference Maurea N, Coppola C, Ragone G et al. (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med (Hagerstown) Maurea N, Coppola C, Ragone G et al. (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med (Hagerstown)
5.
go back to reference de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11:193–203PubMedCrossRef de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11:193–203PubMedCrossRef
6.
go back to reference Denke MA, Pasternak RC (2001) Defining and treating the metabolic syndrome: a primer from the adult treatment panel III. Curr Treat Options Cardiovasc Med 3:251–253PubMedCrossRef Denke MA, Pasternak RC (2001) Defining and treating the metabolic syndrome: a primer from the adult treatment panel III. Curr Treat Options Cardiovasc Med 3:251–253PubMedCrossRef
7.
go back to reference Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28:195–214PubMedCrossRef Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28:195–214PubMedCrossRef
8.
go back to reference Redig AJ, Munshi HG (2010) Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med 123(87):e1–e6PubMed Redig AJ, Munshi HG (2010) Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med 123(87):e1–e6PubMed
9.
go back to reference Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522PubMedCrossRef Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522PubMedCrossRef
10.
go back to reference Jung HS, Myung SK, Kim BS, Seo HG (2012) Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract 95:275–282PubMedCrossRef Jung HS, Myung SK, Kim BS, Seo HG (2012) Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract 95:275–282PubMedCrossRef
11.
go back to reference Redig AJ, Munshi HG (2010) Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy. Oncology (Williston Park) 24:839–844 Redig AJ, Munshi HG (2010) Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy. Oncology (Williston Park) 24:839–844
12.
go back to reference Patterson RE, Flatt SW, Saquib N et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859–865PubMedCrossRef Patterson RE, Flatt SW, Saquib N et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859–865PubMedCrossRef
13.
go back to reference Dai DF, Hwang JJ, Chen CL et al (2010) Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc 109:716–724PubMedCrossRef Dai DF, Hwang JJ, Chen CL et al (2010) Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc 109:716–724PubMedCrossRef
14.
go back to reference Nguyen TH, Tang HK, Kelly P, van der Ploeg HP, Dibley MJ (2010) Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health 10:141PubMedCrossRef Nguyen TH, Tang HK, Kelly P, van der Ploeg HP, Dibley MJ (2010) Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health 10:141PubMedCrossRef
15.
go back to reference Harralson TL, Uplinger N, McLaughlin M (2010) Increasing physical activity: a step toward controlling metabolic syndrome. Diabetes Educ 36:70–71PubMedCrossRef Harralson TL, Uplinger N, McLaughlin M (2010) Increasing physical activity: a step toward controlling metabolic syndrome. Diabetes Educ 36:70–71PubMedCrossRef
16.
go back to reference van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM (2010) The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol 32:171–179PubMedCrossRef van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM (2010) The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol 32:171–179PubMedCrossRef
17.
go back to reference Thomson CA, Thompson PA, Wright-Bea J, Nardi E, Frey GR, Stopeck A (2009) Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) 18:2041–2047CrossRef Thomson CA, Thompson PA, Wright-Bea J, Nardi E, Frey GR, Stopeck A (2009) Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) 18:2041–2047CrossRef
18.
go back to reference Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502PubMedCrossRef Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502PubMedCrossRef
19.
go back to reference Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51PubMedCrossRef Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51PubMedCrossRef
20.
go back to reference Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238PubMedCrossRef Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238PubMedCrossRef
21.
go back to reference Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100PubMedCrossRef Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100PubMedCrossRef
22.
go back to reference Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132PubMedCrossRef Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132PubMedCrossRef
23.
go back to reference Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443PubMedCrossRef Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443PubMedCrossRef
24.
go back to reference Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412PubMedCrossRef Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412PubMedCrossRef
25.
go back to reference Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59:274–280PubMedCrossRef Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59:274–280PubMedCrossRef
26.
go back to reference Matthews CE, Shu XO, Yang G et al (2003) Reproducibility and validity of the Shanghai Women’s Health Study physical activity questionnaire. Am J Epidemiol 158:1114–1122PubMedCrossRef Matthews CE, Shu XO, Yang G et al (2003) Reproducibility and validity of the Shanghai Women’s Health Study physical activity questionnaire. Am J Epidemiol 158:1114–1122PubMedCrossRef
27.
go back to reference Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef
28.
go back to reference Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef
29.
go back to reference Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef
30.
go back to reference Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
31.
go back to reference Irwin ML, Crumley D, McTiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746–1757PubMedCrossRef Irwin ML, Crumley D, McTiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746–1757PubMedCrossRef
32.
go back to reference Beasley JM, Kwan ML, Chen WY et al (2012) Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat 131:637–643PubMedCrossRef Beasley JM, Kwan ML, Chen WY et al (2012) Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat 131:637–643PubMedCrossRef
33.
go back to reference Andrykowski MA, Beacham AO, Jacobsen PB (2007) Prospective, longitudinal study of leisure-time exercise in women with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev 16:430–438PubMedCrossRef Andrykowski MA, Beacham AO, Jacobsen PB (2007) Prospective, longitudinal study of leisure-time exercise in women with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev 16:430–438PubMedCrossRef
34.
go back to reference Littman AJ, Tang MT, Rossing MA (2010) Longitudinal study of recreational physical activity in breast cancer survivors. J Cancer Surviv 4:119–127PubMedCrossRef Littman AJ, Tang MT, Rossing MA (2010) Longitudinal study of recreational physical activity in breast cancer survivors. J Cancer Surviv 4:119–127PubMedCrossRef
35.
go back to reference Golbidi S, Mesdaghinia A, Laher I (2012) Exercise in the metabolic syndrome. Oxid Med Cell Longev 2012:349710PubMedCrossRef Golbidi S, Mesdaghinia A, Laher I (2012) Exercise in the metabolic syndrome. Oxid Med Cell Longev 2012:349710PubMedCrossRef
36.
go back to reference Misra KB, Endemann SW, Ayer M (2005) Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California. Ethnicity Dis 15:627–634 Misra KB, Endemann SW, Ayer M (2005) Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California. Ethnicity Dis 15:627–634
37.
go back to reference Lakka TA, Laaksonen DE (2007) Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32:76–88PubMedCrossRef Lakka TA, Laaksonen DE (2007) Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32:76–88PubMedCrossRef
38.
39.
go back to reference Nuri R, Kordi MR, Moghaddasi M et al (2012) Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther 8:238–242PubMedCrossRef Nuri R, Kordi MR, Moghaddasi M et al (2012) Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther 8:238–242PubMedCrossRef
40.
go back to reference Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef
41.
go back to reference Gu K, Chen X, Zheng Y et al (2010) Weight change patterns among breast cancer survivors: results from the Shanghai Breast Cancer Survival Study. Cancer Causes Control 21:621–629PubMedCrossRef Gu K, Chen X, Zheng Y et al (2010) Weight change patterns among breast cancer survivors: results from the Shanghai Breast Cancer Survival Study. Cancer Causes Control 21:621–629PubMedCrossRef
42.
go back to reference Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N (2010) Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006). Cancer Causes Control 21:283–288PubMedCrossRef Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N (2010) Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006). Cancer Causes Control 21:283–288PubMedCrossRef
43.
go back to reference Wilson DB, Porter JS, Parker G, Kilpatrick J (2005) Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study. Prev Chronic Dis 2:A16PubMed Wilson DB, Porter JS, Parker G, Kilpatrick J (2005) Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study. Prev Chronic Dis 2:A16PubMed
44.
go back to reference Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef
45.
go back to reference US Department of Health and Human Services (2008) Physical activity guidelines for Americans. Okla Nurse 53:25 US Department of Health and Human Services (2008) Physical activity guidelines for Americans. Okla Nurse 53:25
Metadata
Title
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study
Authors
Ping-Ping Bao
Ying Zheng
Sarah Nechuta
Kai Gu
Hui Cai
Peng Peng
Xiao-Ou Shu
Wei Lu
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0252-7

Other articles of this Issue 9/2013

Cancer Causes & Control 9/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine